BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAF8. A total of 42 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $1,966,000 | -74.5% | 1,660,000 | -76.3% | 0.14% | -75.0% |
| Q1 2018 | $7,720,000 | -53.5% | 7,010,000 | -50.0% | 0.55% | +0.7% |
| Q4 2017 | $16,604,000 | +97.9% | 14,020,000 | +100.0% | 0.55% | -5.5% |
| Q3 2017 | $8,390,000 | -20.8% | 7,010,000 | -21.3% | 0.58% | -22.6% |
| Q2 2017 | $10,597,000 | +4.9% | 8,910,000 | +4.1% | 0.75% | +5.2% |
| Q1 2017 | $10,106,000 | +5.0% | 8,560,000 | +4.3% | 0.71% | -2.3% |
| Q4 2016 | $9,622,000 | +16.9% | 8,210,000 | +24.4% | 0.73% | +33.3% |
| Q3 2016 | $8,229,000 | +7.8% | 6,600,000 | 0.0% | 0.55% | +3.4% |
| Q2 2016 | $7,631,000 | +43.0% | 6,600,000 | +46.7% | 0.53% | +35.6% |
| Q1 2016 | $5,335,000 | +24.2% | 4,500,000 | +16.3% | 0.39% | +9.9% |
| Q1 2014 | $4,295,000 | -37.9% | 3,870,000 | -40.2% | 0.36% | -32.8% |
| Q4 2013 | $6,919,000 | – | 6,470,000 | – | 0.53% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|